Company Overview and News

 
PRESS DIGEST- Financial Times - April 2

2018-04-02 reuters
April 2 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

 
Euronext NV 2017 Q4 - Results - Earnings Call Slides

2018-02-20 seekingalpha
The following slide deck was published by Euronext NV in conjunction with their 2017 Q4 earnings call.

 
How Systematic Internalizers Will Change Trading - Bloomberg

2017-12-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Why Bill Gross Believes the Stock Market Has Reached the Top

2017-12-01 marketrealist
On Thursday, November 16, 2017, bond guru Bill Gross shared his views on the stock market (SPY) (IWM), bond yield (BND), and interest rate in an interview with CNBC’s Power Lunch.

 
AnalytixInsight Reports Third Quarter Record Revenues and First Company Profit

2017-11-28 marketwired
TORONTO, ONTARIO--(Marketwired - Nov. 28, 2017) - Artificial Intelligence company, AnalytixInsight Inc. (the "Company" or "AnalytixInsight") (TSX VENTURE:ALY)(OTCQB:ATIXF) today reported record revenues and the Company's first operating profit for the third quarter ended September 30, 2017.

 
MiFID’s Dark-Trading ‘Loophole’ Has New Stock Exchange Opponent - Bloomberg

2017-11-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Euronext NV 2017 Q3 - Results - Earnings Call Slides

2017-11-08 seekingalpha
The following slide deck was published by Euronext NV in conjunction with their 2017 Q3 earnings call.

1
AnalytixInsight Posts Strong Growth During Quarter and Provides Corporate Update

2017-05-30 marketwired
TORONTO, ONTARIO--(Marketwired - May 30, 2017) - Artificial Intelligence company, AnalytixInsight Inc. (TSX VENTURE:ALY) (the "Company" or "AnalytixInsight") reports strong first quarter results on the back of continued growth in the business operations of its subsidiaries.

 
Singapore Exchange said to mull tie-ups as deals grow harder

2017-03-30 themalaymailonline
South-east Asia’s largest stock and derivatives market, SGX, has been in recent exploratory talks about possible tie-ups. — Reuters picSINGAPORE, March 31 — Even as regulators crack down on yet another round of consolidation among exchange operators, at least one major bourse is still keen to pursue deals.

 
Proposed Sale of LCH SA to Euronext NV

2017-03-29 londonstockexchange
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 
EU Blocks Deutsche Boerse's $14 Billion Takeover of London Stock Exchange - Bloomberg

2017-03-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
World's Least Populated National Benchmark Still Has a Vacancy - Bloomberg

2017-03-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Buyout Firms Losing Out to Spinoffs as Nordic Valuations Soar - Bloomberg

2017-03-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Deutsche Borse, LSE to Further Address Antitrust Concerns - WSJ

2017-02-24 wsj
Deutsche Börse AG and London Stock Exchange Group PLC are poised to tweak their previously offered commitments to address antitrust concerns from regulators over plans to create Europe’s largest exchange operator, a person familiar with the matter said.

 
Euronext Seeks Takeover Targets Amid Goliath Rival Tie-Up - Bloomberg

2017-02-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...